AI assistant
HUMANA INC — Director's Dealing 2012
Mar 13, 2012
30145_dirs_2012-03-12_47305141-6740-4614-8fe3-0060c5f2930a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2012-03-09
Reporting Person: HATHCOCK BONNIE C (Sr VP & Chief Human Res. Off)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-09 | Humana Common | M | 41036 | $69.475 | Acquired | 65324 | Direct |
| 2012-03-09 | Humana Common | M | 19351 | $41.83 | Acquired | 84675 | Direct |
| 2012-03-09 | Humana Common | M | 12117 | $46.40 | Acquired | 96792 | Direct |
| 2012-03-09 | Humana Common | M | 7589 | $61.18 | Acquired | 104381 | Direct |
| 2012-03-09 | Humana Common | F | 2287 | $87.39 | Disposed | 102094 | Direct |
| 2012-03-09 | Humana Common | S | 61207 | $87.2056 | Disposed | 40887 | Direct |
| 2012-03-09 | Humana Common | S | 15057 | $87.8468 | Disposed | 25830 | Direct |
| 2012-03-09 | Humana Common | G | 900 | $87.39 | Disposed | 24930 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-09 | Options | $69.475 | M | 41036 | Disposed | 2015-02-21 | Humana Common (41036) | Direct |
| 2012-03-09 | Options | $41.83 | M | 19351 | Disposed | 2016-02-19 | Humana Common (19351) | Direct |
| 2012-03-09 | Options | $46.40 | M | 12117 | Disposed | 2017-02-18 | Humana Common (12117) | Direct |
| 2012-03-09 | Options | $61.18 | M | 7589 | Disposed | 2018-02-17 | Humana Common (7589) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options | $88.6475 | 2019-02-23 | Humana Common (24374) | 24374 | Direct |
| Restricted Stock Units | $ | Humana Common (5149) | 5149 | Direct | |
| Restricted Stock Units | $ | Humana Common (4738) | 4738 | Direct |
Footnotes
F1: Right to buy pursuant to the Company's 2003 Stock Incentive Plan.
F2: Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.
F3: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/19/10 to 2/19/12.
F4: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/18/11 to 2/18/13.
F5: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/17/12 to 2/17/14.
F6: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/23/13 to 2/23/15.
F7: Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.
F8: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F9: Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.
F10: Restricted stock units granted to reporting person on 2/23/12, 100% of the award is vesting on 2/23/15.
F11: This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $86.79 to $87.78. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
F12: This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $87.79 to $88.10. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.